212 related articles for article (PubMed ID: 19010975)
1. Successful duloxetine treatment of a binge eating disorder: a case report.
Bernardi S; Pallanti S
J Psychopharmacol; 2010 Aug; 24(8):1269-72. PubMed ID: 19010975
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment with duloxetine in a case of treatment refractory bulimia nervosa: a case report.
Hazen E; Fava M
J Psychopharmacol; 2006 Sep; 20(5):723-4. PubMed ID: 16401659
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
Turcotte JE; Debonnel G; de Montigny C; Hébert C; Blier P
Neuropsychopharmacology; 2001 May; 24(5):511-21. PubMed ID: 11282251
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine in obese binge eater outpatients: preliminary results from a 12-week open trial.
Leombruni P; Lavagnino L; Gastaldi F; Vasile A; Fassino S
Hum Psychopharmacol; 2009 Aug; 24(6):483-8. PubMed ID: 19536908
[TBL] [Abstract][Full Text] [Related]
5. Biological perspectives. Serotonin and norepinephrine reuptake inhibitors (SNRIs): venlafaxine and duloxetine.
Lee SI; Keltner NL
Perspect Psychiatr Care; 2006 May; 42(2):144-8. PubMed ID: 16677140
[No Abstract] [Full Text] [Related]
6. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.
Wernicke JF; Pritchett YL; D'Souza DN; Waninger A; Tran P; Iyengar S; Raskin J
Neurology; 2006 Oct; 67(8):1411-20. PubMed ID: 17060567
[TBL] [Abstract][Full Text] [Related]
7. Effects of duloxetine on painful physical symptoms associated with depression.
Goldstein DJ; Lu Y; Detke MJ; Hudson J; Iyengar S; Demitrack MA
Psychosomatics; 2004; 45(1):17-28. PubMed ID: 14709757
[TBL] [Abstract][Full Text] [Related]
8. [Duloxetin effective in depression and pain: high remission rates obtained].
MMW Fortschr Med; 2006 Jun; 148(23):63. PubMed ID: 16826744
[No Abstract] [Full Text] [Related]
9. Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
Schatzberg AF
J Clin Psychiatry; 2003; 64 Suppl 13():30-7. PubMed ID: 14552654
[TBL] [Abstract][Full Text] [Related]
10. [Physical complaints can overlap mental symptoms. Diffuse pain? Think about depression!].
MMW Fortschr Med; 2006 Jun; 148(23):62. PubMed ID: 16826743
[No Abstract] [Full Text] [Related]
11. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
Park P; Caballero J; Omidian H
Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607
[TBL] [Abstract][Full Text] [Related]
12. [Duloxetine. A new preparation for patients with urinary incontinence].
Walter S
Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
[TBL] [Abstract][Full Text] [Related]
13. [Successful phase III study with serotonin-noradrenaline reuptake inhibitor. Soon a drug to control stress incontinence].
MMW Fortschr Med; 2004 Feb; 146(7):59. PubMed ID: 15347056
[No Abstract] [Full Text] [Related]
14. [Change in the point of view].
Krankenpfl J; 2005; 43(1-3):23-4. PubMed ID: 15912818
[No Abstract] [Full Text] [Related]
15. Switching from serotonin reuptake inhibitors to duloxetine in patients with resistant obsessive compulsive disorder: a case series.
Dell'osso B; Mundo E; Marazziti D; Altamura AC
J Psychopharmacol; 2008 Mar; 22(2):210-3. PubMed ID: 18208931
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine: a new serotonin/noradrenaline reuptake inhibitor for the treatment of depression.
Rabasseda X
Drugs Today (Barc); 2004 Sep; 40(9):773-90. PubMed ID: 15538550
[TBL] [Abstract][Full Text] [Related]
17. The treatment of urinary incontinence with Duloxetine.
Basu M; Duckett J
J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
[TBL] [Abstract][Full Text] [Related]
18. Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis.
Lam RW; Lönn SL; Despiégel N
Int Clin Psychopharmacol; 2010 Jul; 25(4):199-203. PubMed ID: 20357664
[TBL] [Abstract][Full Text] [Related]
19. [Dual acting reuptake inhibitors in the treatment of depression and pain].
Hajak G
Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S280-3. PubMed ID: 17139587
[TBL] [Abstract][Full Text] [Related]
20. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine.
Trivedi MH; Desaiah D; Ossanna MJ; Pritchett YL; Brannan SK; Detke MJ
Int Clin Psychopharmacol; 2008 May; 23(3):161-9. PubMed ID: 18408530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]